FDA application evidence
ANDA207037
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
Application summary
- Application number
- ANDA207037
- Sponsor
- ALKEM LABS LTD
- Product / brand name
- OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
- Active ingredients
- HYDROCHLOROTHIAZIDE, OLMESARTAN MEDOXOMIL
- Submission type
- SUPPL
- Submission status
- AP
- Submission date
- 20260423
- Review priority
- STANDARD
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- TE code
- AB